thiophenes and Ischemia
thiophenes has been researched along with Ischemia in 26 studies
Research
Studies (26)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.69) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 14 (53.85) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Acar, E; Altunrende, F; Can, O; Canat, L; Eraldemir, FC; Otunctemur, A; Sonmez, K; Yildirim, F | 1 |
| Buono, GM; Fussi, MF; Hidalgo, F; Larocca, MC; Marquez, SB; Molinas, JL; Molinas, SM; Monasterolo, LA; Pariani, AP | 1 |
| Gaikwad, AB; Sharma, N | 1 |
| Li, LU; Zhang, H; Zhao, Y | 1 |
| Çomu, FM; Demirtaş, H; Erer, D; Kılıç, Y; Küçük, A; Mardin, B; Oktar, GL; Özer, A | 1 |
| Baldi, A; Bilel, S; Botrè, F; Cerbelli, B; De-Giorgio, F; Foti, F; Marti, M; Ossato, A; Sangiorgi, E | 1 |
| Bura-Rivière, A; Caradu, C; Chapouly, C; Couffinhal, T; Dubois, M; Ducasse, E; Gadeau, AP; Guimbal, S; Hollier, PL; Renault, MA | 1 |
| Alonso-Canovas, A; Alvarez-Velasco, R; de Felipe Mimbrera, A; Kawiorski, MM; Masjuan, J; Sainz de la Maza, S; Zarza, B | 1 |
| Böhm, M; Gensch, C; Laufs, U; Pavlickova, V; Pöss, J; Schirmer, SH; Werner, CM; Wright, MB | 1 |
| Bohn, RL; Choudhry, NK; Daniel, GW; Gagne, JJ; Liu, J; Patrick, AR; Rassen, JA; Schneeweiss, S; Sridhar, G | 1 |
| Ahrens, I; Bode, C | 1 |
| Baber, U; Mastoris, I; Mehran, R | 1 |
| Abate, M; Levine, JS; Lieberthal, W; Lusco, M; Tang, M | 1 |
| Fareed, J; Jeske, WP; Mousa, SA | 1 |
| Brown, KM; Chen, SW; D'Agati, VD; Kim, M; Lee, HT; Park, SW | 1 |
| Castriota, F; De Luca, G; De Servi, S; Kozinski, M; Kubica, J; Navarese, EP; Schaffer, A; Suriano, P; Verdoia, M | 1 |
| Chatterjee, S; Frankel, R; Ghose, A; Guha, G; Mukherjee, D; Sharma, A | 1 |
| Cho, C; Igarashi, S; Lai, LW; Lien, YH; Yong, KC | 1 |
| Bhatt, DL | 1 |
| Bach-Holm, D; Bang, K; Jensen, PK; Kiilgaard, JF; la Cour, M; Noergaard, MH; Scherfig, E; Stefánsson, E | 1 |
| Katsumura, T | 1 |
| Kamiya, K; Katsumura, T; Mishima, Y; Sakaguchi, S; Sakuma, A; Tanabe, T | 1 |
| Gidday, JM; Zhu, Y | 1 |
| Das, A; McGuire, PG; McLamore, A; Song, W | 1 |
| Battaglia, G; Bond, A; Bruno, V; Clark, BP; Harris, JR; Kingston, AE; Lodge, D; Monn, JA; Nicoletti, F; O'Neill, MJ; Schoepp, DD | 1 |
| Duriez, M; Levy, BI; Mallat, Z; Silvestre, JS; Tamarat, R; Tedgui, A | 1 |
Reviews
4 review(s) available for thiophenes and Ischemia
| Article | Year |
|---|---|
Balancing ischaemia and bleeding risks with novel oral anticoagulants.
Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Ischemia; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Venous Thromboembolism | 2014 |
Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials, Phase III as Topic; Clopidogrel; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Kidney Failure, Chronic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thiophenes; Ticlopidine | 2010 |
Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials.
Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Clopidogrel; Hemorrhage; Humans; Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis.
Topics: Adenosine; Clopidogrel; Hemorrhage; Humans; Ischemia; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; PubMed; Randomized Controlled Trials as Topic; Stents; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine | 2013 |
Trials
2 trial(s) available for thiophenes and Ischemia
| Article | Year |
|---|---|
Therapeutic effect of ticlopidine for ischemic leg ulcers.
Topics: Anticoagulants; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Humans; Ischemia; Leg; Leg Ulcer; Male; Thiophenes; Ticlopidine | 1984 |
Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Elbow; Female; Foot; Humans; Ischemia; Knee; Male; Middle Aged; Pain; Placebos; Platelet Aggregation; Skin Ulcer; Thiophenes; Thromboangiitis Obliterans; Ticlopidine | 1982 |
Other Studies
20 other study(ies) available for thiophenes and Ischemia
| Article | Year |
|---|---|
Protective effect of oltipraz in testicular ischaemia/reperfusion injury: An experimental study.
Topics: Humans; Ischemia; Male; Malondialdehyde; Pyrazines; Rats; Reperfusion Injury; Spermatic Cord Torsion; Testis; Thiones; Thiophenes | 2022 |
Angiotensin II type 2 receptor agonist, compound 21, prevents tubular epithelial cell damage caused by renal ischemia.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Dogs; Dose-Response Relationship, Drug; Imidazoles; Ischemia; Kidney; Kidney Tubules; Madin Darby Canine Kidney Cells; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes; Urothelium | 2021 |
Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diminazene; Imidazoles; Ischemia; Kidney; Liver; Male; Myocardium; Oxidative Stress; Peptide Fragments; Peroxidase; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2020 |
P16INK4a upregulation mediated by TBK1 induces retinal ganglion cell senescence in ischemic injury.
Topics: Animals; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Gene Knockdown Techniques; Intraocular Pressure; Ischemia; Models, Biological; Phosphorylation; Polycomb Repressive Complex 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Retinal Ganglion Cells; RNA, Small Interfering; Signal Transduction; Thiophenes; Tumor Suppressor Protein p53; Up-Regulation | 2017 |
Protective effect of erdosteine on erythrocyte deformability in a rat model of lower limb ischemia/reperfusion injury
Topics: Animals; Disease Models, Animal; Erythrocyte Deformability; Erythrocytes; Expectorants; Hindlimb; Ischemia; Lower Extremity; Rats, Wistar; Reperfusion Injury; Thioglycolates; Thiophenes | 2018 |
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model.
Topics: Animals; Death, Sudden; Heart Rate; Illicit Drugs; Intestines; Ischemia; Kidney; Male; Methamphetamine; Mice, Inbred ICR; Models, Animal; Myocardium; Psychotropic Drugs; Thiophenes; Vasoconstriction | 2019 |
Restoring Endothelial Function by Targeting Desert Hedgehog Downstream of Klf2 Improves Critical Limb Ischemia in Adults.
Topics: Animals; Autocrine Communication; Capillary Permeability; Cells, Cultured; Critical Illness; Cyclohexylamines; Cytokines; Disease Models, Animal; Endothelial Cells; Gene Expression Regulation; Hedgehog Proteins; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Ischemia; Kruppel-Like Transcription Factors; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Neovascularization, Physiologic; Regional Blood Flow; Signal Transduction; Stress, Mechanical; Thiophenes | 2018 |
Successful intravenous thrombolysis in acute ischaemic stroke in a patient on rivaroxaban treatment.
Topics: Administration, Intravenous; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Contraindications; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Ischemia; Middle Cerebral Artery; Morpholines; Rivaroxaban; Stroke; Thiophenes; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2014 |
The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Case-Control Studies; Cell Movement; Cell Proliferation; Cells, Cultured; Coronary Artery Disease; Disease Models, Animal; Endothelial Cells; Hindlimb; Humans; Ischemia; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Oxazoles; PPAR alpha; PPAR gamma; Signal Transduction; Stem Cells; Thiophenes | 2014 |
Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel.
Topics: Aged; Clopidogrel; Cohort Studies; Databases, Factual; Electronic Health Records; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Product Surveillance, Postmarketing; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine | 2014 |
Direct oral anticoagulants in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Factor Xa; Factor Xa Inhibitors; Humans; Ischemia; Morpholines; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes | 2014 |
Preconditioning mice with activators of AMPK ameliorates ischemic acute kidney injury in vivo.
Topics: Acute Kidney Injury; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Biphenyl Compounds; Ischemia; Ischemic Preconditioning; Kidney; Mice; Protective Agents; Pyrones; Ribonucleotides; Thiophenes | 2016 |
Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation.
Topics: Acute Kidney Injury; Animals; Extracellular Signal-Regulated MAP Kinases; Ischemia; Kidney; Liver; Liver Diseases; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Oxadiazoles; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; Reperfusion Injury; Signal Transduction; Sphingosine; Thiophenes | 2010 |
S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure.
Topics: Acute Kidney Injury; Animals; Cell Adhesion Molecules; Down-Regulation; Ischemia; Kidney; Leukocyte Count; Male; Mice; Oxadiazoles; Receptors, Lysosphingolipid; Reperfusion Injury; RNA, Messenger; Thiophenes; Tumor Necrosis Factor-alpha | 2006 |
Intensifying platelet inhibition--navigating between Scylla and Charybdis.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2007 |
Dorzolamide increases retinal oxygen tension after branch retinal vein occlusion.
Topics: Animals; Carbonic Anhydrase Inhibitors; Disease Models, Animal; Fluorescein Angiography; Hypoxia; Injections, Intravenous; Ion-Selective Electrodes; Ischemia; Oxygen; Oxygen Consumption; Partial Pressure; Retina; Retinal Vein Occlusion; Sulfonamides; Swine; Thiophenes | 2008 |
Endothelium-dependent changes in retinal blood flow following ischemia.
Topics: Acetylcholine; Adenosine; Animals; Animals, Newborn; Blood Flow Velocity; Endothelin Receptor Antagonists; Endothelium, Vascular; Enzyme Inhibitors; Fluorescein Angiography; Hyperoxia; Hypoxia; Ischemia; Isoxazoles; Nitric Oxide Synthase; omega-N-Methylarginine; Reperfusion; Retinal Vessels; Swine; Thioinosine; Thiophenes | 1998 |
Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.
Topics: Animals; Animals, Newborn; Collagenases; Disease Models, Animal; Gelatinases; Injections, Intraperitoneal; Ischemia; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Phenylalanine; Protease Inhibitors; Retina; Retinal Neovascularization; Retinal Vessels; Thiophenes; Urokinase-Type Plasminogen Activator | 1999 |
Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.
Topics: Animals; Benzoates; Bridged Bicyclo Compounds; Cells, Cultured; Cerebral Cortex; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Gerbillinae; Glycine; Ischemia; Male; N-Methylaspartate; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Thiophenes | 1999 |
Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis.
Topics: Angiography; Animals; Blood Flow Velocity; Capillaries; Disease Models, Animal; Endothelial Growth Factors; Enzyme Activation; Femoral Artery; Fibroblast Growth Factor 2; Hindlimb; Interleukin-10; Ischemia; Laser-Doppler Flowmetry; Lymphokines; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Phenylalanine; Platelet Endothelial Cell Adhesion Molecule-1; Protease Inhibitors; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |